当前位置:首页 - 行情中心 - 泰格医药(300347) - 财务分析

泰格医药

(300347)

  

流通市值:345.00亿  总市值:521.10亿
流通股本:5.78亿   总股本:8.72亿

泰格医药(300347)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润3.13亿元,每股收益0.27元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益2453329.19万元,未分配利润900986.68万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产3007018.55万元,负债553689.36万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入1,660,204,321.447,384,039,460.885,650,477,938.013,710,850,371.59
营业总成本1,305,287,804.375,554,124,713.544,142,186,555.142,720,025,504.93
营业利润362,196,228.412,486,940,557.422,311,724,272.621,598,597,788.22
利润总额362,364,203.952,488,533,058.162,314,469,415.051,599,145,093
净利润312,570,373.392,149,926,843.572,027,846,971.741,408,089,992.74
其他综合收益-22,239,213.9153,516,065.6966,970,735.88103,163,104.24
综合收益总额290,331,159.482,203,442,909.262,094,817,707.621,511,253,096.98
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计11,661,670,938.8311,344,141,125.2111,465,404,979.7311,976,418,436.1
非流动资产合计18,408,514,552.3418,336,601,223.9618,607,044,433.1317,690,257,295.96
资产总计30,070,185,491.1729,680,742,349.1730,072,449,412.8629,666,675,732.06
流动负债合计4,463,914,497.714,138,736,291.584,272,088,045.834,633,250,533.09
非流动负债合计1,072,979,118.961,088,443,912.331,249,127,842.731,075,575,608.78
负债合计5,536,893,616.675,227,180,203.915,521,215,888.565,708,826,141.87
归属于母公司股东权益合计21,131,829,587.0521,026,774,725.7521,059,877,997.1720,586,103,937.27
股东权益合计24,533,291,874.524,453,562,145.2624,551,233,524.323,957,849,590.19
负债和股东权益合计30,070,185,491.1729,680,742,349.1730,072,449,412.8629,666,675,732.06
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计1,549,726,817.367,095,305,409.425,303,391,474.823,498,591,573.61
经营活动现金流出小计1,405,522,357.295,944,867,467.374,630,746,993.263,123,550,318.27
经营活动产生的现金流量净额144,204,460.071,150,437,942.05672,644,481.56375,041,255.34
投资活动现金流入小计162,647,537.341,293,893,974.05730,707,309.57404,985,024.55
投资活动现金流出小计282,364,101.452,828,118,716.522,323,212,158.131,113,544,944.53
投资活动产生的现金流量净额-119,716,564.11-1,534,224,742.47-1,592,504,848.56-708,559,919.98
筹资活动现金流入小计447,503,471.273,596,068,529.073,057,685,789.541,703,330,972.76
筹资活动现金流出小计445,078,699.33,603,874,589.352,582,824,548.021,082,260,769.84
筹资活动产生的现金流量净额2,424,771.97-7,806,060.28474,861,241.52621,070,202.92
汇率变动对现金及现金等价物的影响-5,074,061.178,793,343.5322,207,055.1425,879,265.82
现金及现金等价物净增加额21,838,606.76-382,799,517.17-422,792,070.34313,430,804.1
期末现金及现金等价物余额7,421,779,976.617,399,941,369.857,359,948,816.688,096,171,691.12
最新报告期:2024-04-29
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
开源证券余汝意2.572.853.232024-04-29
中泰证券崔少煜,祝嘉琦2.633.133.942024-04-28
国泰君安丁丹,甘坛焕2.582.993.392024-04-28
平安证券叶寅,倪亦道2.603.204.022024-04-26
浙商证券孙建,郭双喜2.542.973.572024-04-17
TOP↑